David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIT
426
DELISTED
CIT Group Inc.
CIT
| $27.2M | 0.05% |
877,072
+739,619
| +538% | +$23.3M |
|
427
MGM Resorts International
MGM
$11B
| $27.1M | 0.05% |
1,265,995
-478,797
| -27% | -$9.46M |
|
428
Plains GP Holdings
PAGP
$5.31B
| $27.1M | 0.05% |
1,170,204
+350,054
| +43% | +$7.19M |
|
429
Snap-on
SNA
$20.3B
| $26.7M | 0.05% |
170,176
-12,304
| -7% | -$1.88M |
|
430
Zurn Elkay Water Solutions
ZWS
$8.13B
| $26.7M | 0.05% |
2,737,000
-294,155
| -10% | -$2.5M |
|
431
CALL
Kinder Morgan
KMI
$69B
| $26.5M | 0.05% |
1,485,300
+1,004,000
| +209% | +$16.4M |
|
|
CVA
432
DELISTED
Covanta Holding Corporation
CVA
| $26.5M | 0.05% |
1,572,955
+652,160
| +71% | +$9.62M |
|
433
PUT
Wynn Resorts
WYNN
$10.3B
| $26.5M | 0.05% |
283,800
-444,000
| -61% | -$32.8M |
|
434
Autodesk
ADSK
$53.6B
| $26.5M | 0.05% |
453,753
+153,071
| +51% | +$7.98M |
|
435
Bruker
BRKR
$9.07B
| $26.2M | 0.05% |
935,768
+372,926
| +66% | +$9.3M |
|
436
PUT
Micron Technology
MU
$1.09T
| $26M | 0.05% |
2,482,200
+685,300
| +38% | +$7.66M |
|
437
Medtronic
MDT
$119B
| $25.7M | 0.05% |
342,192
-201,572
| -37% | -$15.2M |
|
438
State Street SPDR Dow Jones International Real Estate ETF
RWX
$267M
| $25.5M | 0.05% |
615,780
-32,854
| -5% | -$1.27M |
|
439
Republic Services
RSG
$67.6B
| $25.5M | 0.05% |
535,705
+262,938
| +96% | +$11.9M |
|
440
CALL
American Airlines Group
AAL
$9.15B
| $25.5M | 0.05% |
622,300
-79,700
| -11% | -$3.21M |
|
|
GAP
441
The Gap Inc
GAP
$7.13B
| $25.5M | 0.05% |
867,376
+701,863
| +424% | +$18.4M |
|
|
AGU
442
DELISTED
Agrium
AGU
| $25.5M | 0.05% |
288,308
-1,205,747
| -81% | -$104M |
|
443
PUT
Las Vegas Sands
LVS
$30.5B
| $25.4M | 0.05% |
491,000
-533,000
| -52% | -$24.4M |
|
444
Southern Company
SO
$102B
| $25.3M | 0.05% |
489,219
+329,072
| +205% | +$16M |
|
445
CALL
ConocoPhillips
COP
$162B
| $25.2M | 0.05% |
626,600
+67,500
| +12% | +$2.57M |
|
446
PUT
Regeneron Pharmaceuticals
REGN
$85.9B
| $25.2M | 0.05% |
70,000
-80,200
| -53% | -$33M |
|
|
PPS
447
DELISTED
Post Properties
PPS
| $25.2M | 0.05% |
421,408
+198,518
| +89% | +$11.3M |
|
448
CALL
Visa
V
$693B
| $25.1M | 0.05% |
328,600
-586,100
| -64% | -$42.6M |
|
449
CALL
DuPont de Nemours
DD
$18.7B
| $25M | 0.04% |
194,400
+93,113
| +92% | +$11.2M |
|
|
CNL
450
DELISTED
CLECO CRP (HOLDING CO)
CNL
| $25M | 0.04% |
452,435
+353,944
| +359% | +$18M |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.